Café

© 2026 Longbridge｜Terms of Service Privacy Policy

CRISPR Therapeutics Provides Business Update and Reports Second Quarter 2026 Financial Results

CRISPR Therapeutics Provides Business Update and Reports Second Quarter 2026 Financial Results

Unusual Whales

Aug 3, 2026 at 03:18 PM

In Zug, Switzerland and Boston, financial results for the second quarter ending on June 30, 2026 were reported by CRISPR Therapeutics (Nasdaq: CRSP).

Source: Unusual Whales The copyright of this article belongs to the original author/organization.

The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.

CRISPR Therap

CRSP.US

Open

--

High

--

Low

--

Prev Close

--

P/E^TTM

--

Market Cap

--

LongbridgeAI